Related Experiment Video
Updated: Mar 11, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
MML-DTI: Multimanifold Learning with Hyperbolic Graph Neural Networks for Enhanced Drug-Target Interaction Prediction
Haotian Guan1,2, Tian Bai1,2, Chuande Yang3,2
1College of Computer Science and Technology, Jilin University, No. 2699 Qianjin Street, Changchun, Jilin 130012, China.
None:
Accurately predicting drug-target interactions (DTIs) is crucial for drug discovery, repositioning. However, most deep learning-based DTI models are designed in Euclidean space, making it difficult to effectively represent the hierarchical and scale-free characteristics of biological data. Due to its unique negatively curved geometric properties, hyperbolic space can more effectively represent hierarchical relationships within data. Therefore, we propose a multimanifold learning framework that integrates multimodal features in hyperbolic and Euclidean spaces for drug-target interaction prediction. Specifically, we employ a Hyperbolic Graph Neural Network (HGNN) to extract features from molecular graphs of small-molecular drugs, thereby effectively capturing the hierarchical structural information within these graphs. To integrate heterogeneous information, a Multi-Manifold Feature Fusion Module combines structural features from the HGNN, chemical fingerprints, and semantic embeddings derived from pretrained language models. Extensive experiments on benchmark data sets demonstrate that our framework achieves superior performance compared with state-of-the-art Euclidean-based methods. The experimental results demonstrate that hyperbolic geometry offers significant advantages in extracting hierarchical features from non-Euclidean data and also highlight the promising potential of multimanifold feature fusion in the field of drug-target interaction prediction.
Related Concept Videos
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacogenomics: Identification of New Drug Targets
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....

